Specific renal histopathological findings related to cardiovascular disease risk in patients with CKD

Published Date: 10 Mar 2023

Chronic renal failure (CKD) is a risk factor for cardiovascular diseases such as heart attacks, strokes or heart failure. Brigham the scientist...

Read Full News

Latest News

DOACs Benefit AF Patients With Intermediate Stroke Risk

Anticoagulation reduced adverse clinical events in patients with atrial fibrillation at intermediate stroke risk, without an apparent increase in major bleeding.

Heart Failure Drug May Not Improve Exercise Fitness in nHCM

A heart failure drug combination may not improve exercise capacity in patients with nonobstructive hypertrophic cardiomyopathy but is associated with favorable cardiac structural remodeling.

Mounjaro FDA-Approved to Reduce Cardiovascular Risk in T2D

Lilly's Mounjaro (tirzepatide) is now approved to reduce cardiovascular risk in adults with type 2 diabetes.

Weight Down, Steps Down: The GLP-1 Catch

Studies suggest that strong recommendations for exercise with GLP-1s are commonly not heeded; possible reasons vary.

Ginseng, the ‘Miracle Root’: How Strong Is the Evidence?

Evidence varies across ginseng uses, with some potential benefits but limited support for treating fatigue, cognitive decline, infections, diabetes, or cardiovascular disease.

Inpatient Weight Loss May Cut HF Rehospitalization Risk

Losing weight during hospitalization for heart failure in patients treated with intravenous loop diuretics is associated with a reduced 30-day risk for rehospitalization.

Todays Updates

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Phase 3 Eplontersen Trial Results Disappoint

Despite a major reduction in transthyretin amyloid deposits, eplontersen, a drug that reduces TTR production, did not reduce events associated with TTR amyloidosis in a phase 3 trial.

Todays Updates

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Phase 3 Eplontersen Trial Results Disappoint

Despite a major reduction in transthyretin amyloid deposits, eplontersen, a drug that reduces TTR production, did not reduce events associated with TTR amyloidosis in a phase 3 trial.

Latest News

Anticoagulation reduced adverse clinical events in patients with atrial fibrillation at intermediate stroke risk, without an apparent increase in major bleeding.

A heart failure drug combination may not improve exercise capacity in patients with nonobstructive hypertrophic cardiomyopathy but is associated with favorable cardiac structural remodeling.

Lilly's Mounjaro (tirzepatide) is now approved to reduce cardiovascular risk in adults with type 2 diabetes.

Studies suggest that strong recommendations for exercise with GLP-1s are commonly not heeded; possible reasons vary.

Evidence varies across ginseng uses, with some potential benefits but limited support for treating fatigue, cognitive decline, infections, diabetes, or cardiovascular disease.

Losing weight during hospitalization for heart failure in patients treated with intravenous loop diuretics is associated with a reduced 30-day risk for rehospitalization.

News All Time

Vutrisiran May Stabilize Right Ventricle Function in ATTR-CM

Right ventricular dysfunction is linked to worse outcomes in patients with transthyretin amyloidosis with cardiomyopathy; vutrisiran treatment may help stabilize right ventricular function.

Inhaling Cannabis Tied to Less Cardiac Ectopy in Adults

Adults without a history of cardiac arrhythmias have less cardiac ectopy on days they were randomly assigned to inhale cannabis than on days they abstained.

Mildly Elevated Ketones May Protect Kidneys in T2D

In patients with type 2 diabetes, mildly elevated blood ketone body levels are associated with a lower risk of developing kidney complications, a study finds.

Common ASM Tied to Twofold Thromboembolic Risk With DOACs

Levetiracetam has been linked to an increased thromboembolic risk among adults with epilepsy receiving DOACs, but experts caution that, at this point, the finding is not practice-changing.

An Accordion’s Unlikely Assist in Heart Research

Researchers applied the physics of the instrument to a new device that reproduces the heart’s complex blood flow waveforms.

Mushrooms Gain Ground in Medicine Despite Limited Evidence

Mushroom compounds show potential across cancer, metabolic, and neurologic research, but most evidence remains preclinical and larger clinical trials are still needed.

Doctors Need Friends Outside Medicine, and It’s Not Easy

Doctors may find their closest friends in medicine and have little time for others. But experts say friendships outside the medical bubble matter more than ever.

Cardioprotection Rarely Used in Adults With Blood Cancers

Few adults on anthracycline chemotherapy for hematologic cancers receive strategies to protect their hearts.

Breakthrough Stroke in AF Linked to Drug Interactions

Patients who experience ischemic stroke despite ongoing oral anticoagulation for atrial fibrillation often have identifiable causes such as drug interactions or non-cardioembolic disease.

Medicine on Screen: 10 Films Doctors May Want to Rewatch

From Alzheimer’s to pandemics, these films show how medicine is lived as much as it is practiced.

Sequential or Simultaneous Therapy in Chronic Kidney Disease

Experts debate the pros and cons of stepwise vs simultaneous therapy for chronic kidney disease in an era of multifactorial treatment choices.

Deep Dive: DPP-4 Inhibitors After the ADA Downgrade

ADA now says limit or discontinue gliptins. Cardiologist Benjamin Scirica, MD, on why sitagliptin still looks safest of the four.

New Tool May Identify Adverse Events in Hospitalized Kids

A new trigger tool can help identify adverse events in hospitalized children, showing good reviewer agreement and aiding the systematic detection of patient harm.

Central Obesity Reveals Hidden Risk in Overweight

Adding waist-based central obesity measures to BMI may improve the identification of risk for multimorbidity in adults with BMI-defined overweight.

Canada Joins Global Call for Exercise Physiology for Obesity

A new joint global statement says that exercise physiologists should be part of a multidisciplinary obesity care team for patients taking weight management medications.

Fitness Changes Over Time Linked to Cardiovascular Risk

In adults, changes in cardiorespiratory fitness over time — not just a single measurement — are linked to their risks for cardiovascular disease and death.

Recommended News For You

Nuclear missile workers are contracting cancer: They blame the bases

High Rate of Deep Remission for Relapsed/Refractory CLL Using Triple Regimen.

Morning Immunotherapy Does Not Boost Lung Cancer Survival

New methods show how fast breast cancers grow and how surgery delays affect cancer staging

New clinical recommendation for local treatment of oligometastatic lung cancer.

A study outlines the need for policies that enhance cancer patients' autonomy and information.

Radiation therapy for patients with breast cancer

Recommended Articles For You

Demystifying Hypereosinophilic Syndrome: Symptoms, Diagnosis, and Treatment Options  

Precision Risk Mapping in Cancer Prevention Programs 

The Algorithmic Oncologist: A Comparative Clinical Review of AI in Predictive Cancer Planning 

Exploring the Hope of New Treatments for Rhabdomyosarcoma 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New Immune Therapy Boosts Disease Control in Prostate Cancer

2.

According to the Lancet, proton beam therapy may shorten the course of treatment for patients with breast cancer.

3.

Stem Cell Transplant Associated With Better PFS in NKTCL

4.

Liver cancer cells under pressure: Compression can spark invasion, drug resistance and altered gene activity

5.

Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap

1.

Artificial Intelligence for Bone Marrow Cellular Ecosystem Modeling

2.

Exploring the Causes and Treatments of Bacterial Keratitis: A Comprehensive Guide

3.

Pharmacological Frontier of Precision Oncology, Immunotherapies, and the Evolving Art of Treatment

4.

All You Need To Know About Partial Thromboplastin Time (PTT) Test

5.

Role of Type I Interferons and KDM1B in Driving Cancer Stemness and Therapeutic Evasion

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Expert Perspectives on Hematology

2.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?

3.

Nutrition During Cancer Treatment

4.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective

5.

Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot